A prospective study on the efficacy of modified ALCL99 regimens in the treatment of the current Chinese pediatric and adolescent high-risk ALCL and compared with our historical data.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
3-year event free survival (EFS)
Timeframe: Up to 3 years
Treatment-related adverse events
Timeframe: Up to 3years